Clinical Trial: A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196501) titled 'A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)' on Sept. 19.

Brief Summary: The primary objective of this study is to evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in delaying relapse of depressive symptoms (maintenance of effect) in participants with MDD.

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder

Intervention: DRUG: NBI-1065845

Oral tablet

DRUG: Placebo

Oral tablet

Recruitment Status: RECRUITING

Sponsor: Neurocrine Biosciences

Published by HT ...